Physician

Tracy Ann Proverbs-Singh, M.D.

According to 2025 Medicare claims, Tracy Proverbs-Singh, M.D. (NPI: 1730321662) practices hematology/oncology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Hudson, NJ. This provider's primary affiliated billing organization is REGIONAL CANCER CARE ASSOCIATES LLC (NPI: 1801850243; TIN: 223141761) and primary practice location at 07047-6282.

Proverbs-Singh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 549 traditional Medicare patients, billed 69,894 HCPCS/CPT codes, and received $1,089,219 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 646 prescription claims across 169 beneficiaries totaling $888,065 in drug costs, led by Lonsurf (Trifluridine/Tipiracil Hcl). DME data shows 1,000 claims. Open Payments data shows 52 records totaling $1,015. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $92,767 to $1,089,219. Similarly, Part D prescription costs have risen steadily, from $16,791 to $888,065. In contrast, DME billing represents a smaller volume and moved from a lower plateau to a higher plateau, from $20,348 to $39,693.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	197	4,531	$92,767
2017	531	34,496	$547,319
2018	611	43,565	$953,106
2019	551	53,588	$1,091,105
2020	440	42,641	$1,298,081
2021	457	69,049	$1,408,119
2022	598	68,471	$1,512,830
2023	504	39,508	$951,402
2024	549	69,894	$1,089,219

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	17	28	$16,791
2017	108	426	$317,759
2018	151	649	$485,865
2019	155	626	$282,355
2020	144	736	$274,160
2021	170	805	$392,616
2022	157	769	$909,451
2023	134	655	$1,426,111
2024	169	646	$888,065

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	84	505	$41,936
2018	166	701	$42,981
2019	179	1,280	$89,583
2020	101	810	$40,516
2021	160	1,068	$47,063
2022	197	974	$44,309
2023	155	898	$46,120
2024	157	1,000	$46,612

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	229	1,051	$149
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	307	677	$106
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	90	182	$66
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	368	1,284	$14
96372	Injection of drug or substance under skin or into muscle	66	290	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lonsurf	Trifluridine/Tipiracil Hcl	14	392	$178,051
Creon	Lipase/Protease/Amylase	20	595	$34,701
Eliquis	Apixaban	14	480	$9,201
Prochlorperazine Maleate	Prochlorperazine Maleate	98	767	$868
Ondansetron Hcl	Ondansetron Hcl	138	1,081	$691

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0781	Ambulatory infusion pump, single or multiple channels, electric or battery operated, with administrative equipment, worn by patient	Y	31	121	$23,958
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	42	281	$10,656
J9190	Injection, fluorouracil, 500 mg	N	42	291	$5,928
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	42	261	$5,006
J8521	Capecitabine, oral, 500 mg	N	N/R	17	$587

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	52	$1,015	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Tracy Ann Proverbs-Singh, M.D.?

Tedicare shows public-source Medicare data for Tracy Ann Proverbs-Singh, M.D. (NPI 1730321662), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Tracy Ann Proverbs-Singh, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Tracy Ann Proverbs-Singh, M.D.?

Tracy Ann Proverbs-Singh, M.D. is linked to REGIONAL CANCER CARE ASSOCIATES LLC (billing NPI 1801850243) in the available physician profile data.

Does Tracy Ann Proverbs-Singh, M.D. have Open Payments data?

Tracy Ann Proverbs-Singh, M.D. has 52 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.